Pak Fah Yeow International Limited (00239.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 18Aug 21Aug 26Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

1.6x

Market Cap

HKD 779.10M

MomentumView details →

1D Return

−0.79%

YTD Return

+5.49%

RSI (14)

54.2

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

1.6x

Market Cap

HKD 779.10M

RSI (14)

54.2

MomentumView details →

1D Return

−0.79%

YTD Return

+5.49%

ProfitabilityView details →

Gross Margin

74.81%

Net Margin

40.48%

EBITDA Margin

56.78%

ROE (TTM)

23.15%

ROA (TTM)

19.35%

Asset Turnover

0.49x

GrowthView details →

Revenue YoY

−13.10%

EPS YoY

−6.78%

FCF YoY

−57.40%

Revenue CAGR 3Y

+13.26%

EPS CAGR 3Y

+44.51%

EBITDA YoY

−11.01%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.01x

Current Ratio

7.23x

Quick Ratio

6.98x

Div Yield

7.60%

Div Rate

HKD 0.19

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

419.73M

Net Income (TTM)

169.92M

Op. CF (TTM)

—

Latest newsMore news →

No recent news for 00239.HK.

Similar companies

Esperion Therapeutics, Inc.ESPR Collegium Pharmaceutical, Inc.COLL Lee's Pharmaceutical Holdings Limited00950.HK Ironwood Pharmaceuticals, Inc.IRWD Aquestive Therapeutics, Inc.AQST Evotec SEEVO Find similar companies →

Latest newsMore news →

No recent news for 00239.HK.